Learn Before
COVID-19 Pharmacology Papers from Clinical Infectious Diseases
Long-Term ACE Inhibitor/ARB Use Is Associated with Severe Renal Dysfunction and Acute Kidney Injury in Patients with severe COVID-19: Results from a Referral Center Cohort in the North East of France
Oussalah, A., Gleye, S., Clerc Urmes, I., Laugel, E., Callet, J., Barbé, F., Orlowski, S., Malaplate, C., Aimone-Gastin, I., Maatem Caillierez, B., Merten, M., Jeannesson, E., Kormann, R., Olivier, J., Rodriguez-Guéant, R., Namour, F., Bevilacqua, S., Losser, M., Levy, B., Kimmoun, A., Gibot, S., Thilly, N., Frimat, L., Schvoerer, E., & Guéant, J. (2020). Long-Term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa677
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Long-Term ACE Inhibitor/ARB Use Is Associated with Severe Renal Dysfunction and Acute Kidney Injury in Patients with severe COVID-19: Results from a Referral Center Cohort in the North East of France
COVID-19 Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
Long-Term Outcome of Short-Course High-Dose Glucocorticoids for SARS: a 17-Year Follow-Up in SARS Survivors